Lotte Biologics Invests Big in South Korea

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking three active projects from Lotte Biologics (Seoul, South Korea) in Yeonsu, South Korea, requiring a total investment value of US$3 billion. The projects include one grassroot plant that will be followed by two additions that are aimed at the production of active pharmaceutical ingredients.

As a project to build three production buildings sequentially, the first began construction in March, and the subsequent buildings will be constructed in two-year intervals.

Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical-Biotech Project Database can learn more by viewing by the related project reports.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).